REGENXBIO INC. (RGNX)
Clinical trial NCT04597385 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-09-01 → 2028-10-01 3. primary completion date: 2025-09-01 → 2028-10-01 4. enrollment: 12 → 27 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical